Organization
Galapagos NV
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Galapagos NV
... Mechelen, Belgium; 7 January 2018, 22.00 CET - Galapagos NV (Euronext & NASDAQ: GLPG) reports positive preliminary topline results with a ...
... with backup novel C1 corrector GLPG2851, triggering $10 M milestone payment to Galapagos from AbbVie - First dosing of PELICAN Phase 2 study of C2 ...
... Mechelen, Belgium; 18 December 2017; 7.30 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Gilead Sciences, ...
... Mechelen, Belgium - Galapagos NV (Euronext & NASDAQ: GLPG) announces that it will be included in ...
... Mechelen, Belgium - regulated information Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Fidelity Management ...
... AG, Corvus Pharmaceuticals Inc., CytomX Therapeutics Inc., Dova Pharmaceuticals Inc., Endocyte, Inc., Galapagos NV, GlycoMimetics, Inc., G1 Therapeutics Inc., ImmunoGen Inc., Jounce Therapeutics, Inc., Kala ...
... on 31 December 2017 Mechelen, Belgium; 14 December 2017; 22.01 CET - Galapagos NV (Euronext & NASDAQ: GLPG) announced today the decision to opt-in on ...
... Mechelen, Belgium; 11 December 2017; 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Fidelity Management ...
... Inc. Nasdaq DOVA Dova Pharmaceuticals, Inc. Nasdaq ECYT Endocyte, Inc. Nasdaq GLPG Galapagos NV Nasdaq GLYC GlycoMimetics, Inc. Nasdaq GTHX G1 Therapeutics, Inc. Nasdaq IMGN ...
... Mechelen, Belgium - Galapagos NV (Euronext & NASDAQ: GLPG) announces initiation of a Phase 1 study ...
... Mechelen, Belgium - 22.01 CET; regulated information Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from ...
... candidate in cystic fibrosis portfolio Mechelen, Belgium; 21 November 2017; 22.01 CET -Galapagos NV (Euronext & NASDAQ: GLPG) announces initiation of a Phase 1 study ...
... in vitro predictive platform Mechelen, Belgium; 19 November 2017, 22.01 CET - Galapagos NV (Euronext & NASDAQ: GLPG) reports positive topline results from its ALBATROSS ...
... Mechelen, Belgium - 3 PM CET Galapagos NV (Euronext & NASDAQ: GLPG) announced additional long-term follow-up data for the ...
... Mechelen, Belgium - At the North American Cystic Fibrosis Conference (NACFC) 2017, Galapagos NV (Euronext & NASDAQ: GLPG) will show progress in both understanding of ...
... Galapagos presents data from DARWIN 3, other filgotinib studies and Galapagos' GLPG1972 at ...
... the full report: Cipla Inc. Prometic Life Sciences Inc. Bristol-Myers Squibb Company Galapagos NV Merck & Co., Inc. Promedior, Inc. FibroGen, Inc. F. Hoffmann-La Roche ...
... 7.30 CET - At the North American Cystic Fibrosis Conference (NACFC) 2017, Galapagos NV (Euronext & NASDAQ: GLPG) will show progress in both understanding of ...
... very dense; we implemented two prominent strategic partnerships with the biotech company Galapagos and the Tasly Group, one of the top ten pharmaceutical companies in ...
... development worldwide Mechelen, Belgium and Planegg/Munich, Germany; 27 September 2017; 7.30 CET -Galapagos NV (Euronext & NASDAQ: GLPG) and MorphoSys AG (FSE: MOR; Prime Standard ...
... further down Mechelen, Belgium; 9 August 2017; 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announces positive topline results with its autotaxin ...
... the MOR106 study in atopic dermatitis." "In the first half of 2017 Galapagos continued to invest in its R&D pipeline to produce substantial progress. The ...
... it has exercised its option to develop novel osteoarthritis molecule GLPG1972/S201086 from Galapagos NV (Euronext/NASDAQ: GLPG), thus obtaining global commercial rights outside the U.S. Osteoarthritis ...
Want to see the full history on Galapagos NV? Upgrade to RelSci Pro now!
Start My Free Trial